Combining antiangiogenic agents, such as saikosaponin b2 which targets the VEGF/ERK/HIF-1 pathway, with immunotherapy enhances treatment efficacy
Collagen Peptide l mt dng thy phn ca loi Collagen thng thng
Supplied as a general-purpose sterile laboratory reagent
Specifically, among treatment agent, Schisandrin C demonstrated the largest effect size with concomitant reduction in heterogeneity [SMD = 7.52, 95% CI (10.13, 4.91), I 2 = 0.0%, p = 0.579]
It is also known by the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
The peak heart rate effect is temporary, not permanent